Prata, Ndola
Weidert, Karen
Dushimeyesu, Evangeline
Kanyamanza, Eugène
Blaise, Dushimiyimana
Umutesi, Sharon
Ngoga, Eugène
Sayinzoga, Felix
Funding for this research was provided by:
David and Lucile Packard Foundation (2020-71324, 2020-71324, 2020-71324, 2020-71324, 2020-71324, 2020-71324, 2020-71324, 2020-71324)
Article History
Received: 20 November 2024
Accepted: 4 April 2025
First Online: 7 May 2025
Declarations
:
: This study adhered to the Declaration of Helsinki. Institutional Review Board approval for this research was obtained from the University of California, Berkeley (CPHS #2020–12 - 13886) and the Rwanda National Ethics Committee (No.620/RNEC/2021). Participants were asked for their informed consent for both the medication abortion and enrollment in the study. They were asked to consent to follow-up for the client exit interview and provide consent before the client exit interview was conducted.
: Not applicable.
: The authors declare no competing interests.